U.S. Markets closed

Failed marijuana experiment slams Organigram earnings

Max A. Cherney
Failed marijuana experiment slams Organigram earnings

Organigram Holdings Inc. said Monday that growing marijuana cost it nearly 50% more in cash and harmed its earnings last quarter because the cannabis company tried — and failed — to develop a more efficient growing technique.